Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin-repaglinide interaction and SLCO1B1 polymorphism study in healthy Chinese male volunteers
ACTRN12611001254987Phase 4Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pitavastatin and repaglinide (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Effects of pitavastatin pretreatment on repaglinide pharmacokinetics and Effect of pitavastatin pretreatment on repaglinide pharmacokinetics and association with SLCO1B1 genetic polymorphisms. Started Mar 2009; status: completed.
02
Drugs
pitavastatinrepaglinide
Beyond the preview
Go deeper on ACTRN12611001254987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001254987.